GSK, Ionis hepatitis B functional cure breaks open market for followers
The approval of Hibsago has created a new market for a handful of biopharmas, including Gilead, Arrowhead, and Vir, to fill in.
GSK, Ionis hepatitis B functional cure breaks open market for followers Read More »
